Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clay-Park Labs was a prominent American pharmaceutical company specializing in the development and manufacture of generic topical medications. Based in the Bronx, New York, the company produced a wide range of prescription and over-the-counter products, including creams, ointments, gels, and oral liquids. Founded in 1975, it established a strong reputation for manufacturing high-quality dermatological generics. In 2004, Clay-Park Labs was acquired by Agis Industries for approximately 130 million dollars. Following Perrigo's acquisition of Agis in 2005, the Clay-Park operations were integrated into Perrigo's global manufacturing network. The Bronx facility remains a significant site for Perrigo's topical product division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clay-Park Labs.